Avanos Medical (AVNS) | Stock Overview & Key Data
Avanos Medical Performance Comparison
Stock Range
Today's Range
Low: $11.76
High: $12.09
on July 29, 2025
52 Week Range
Low: $11.21
High: $25.36
on July 16, 2025
on September 20, 2024
All-Time High: $72.96 on September 3, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$555.4M
EPS
-8.27
P/E Ratio (TTM)
34.37
Forward P/E
7.19
P/B Ratio
0.66
PEG Ratio
7.19
Div. Yield
N/A
ROE
-36.78%
Beta
1.124
Debt to Equity
16.79
Financial Highlights
Profitability
Gross Margin
53.61%
Operating Margin
6.15%
Profit Margin
-55.80%
Returns and Earnings
Return on Assets (TTM)
2.26%
Return on Equity (TTM)
-36.78%
EBITDA
$91.1M
Net Income (TTM)
$-380.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$14.99
Quarterly Revenue Growth (YoY)
0.80%
Quarterly Earnings Growth (YoY)
0.84%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical AVNS | 555.39M Small-cap | 0.17% | -3.19% | -6.77% | -31.46% | -25.14% | -50.65% | -58.87% | -61.95% |
| Abbott Laboratories ABT | 219.83B Mega-cap | 1.81% | -5.88% | -1.91% | 0.12% | 12.84% | 15.00% | 17.17% | 26.45% |
| Boston Scientific BSX | 157.52B Large-cap | 3.21% | -0.88% | 3.63% | 3.66% | 19.12% | 42.91% | 160.06% | 173.21% |
| UFP Technologies UFPT | 1.86B Small-cap | 2.84% | -2.66% | 12.32% | -13.40% | -3.48% | -24.85% | 166.60% | 431.34% |
| QuidelOrtho QDEL | 1.85B Small-cap | -0.39% | -11.73% | -10.99% | -41.54% | -43.52% | -39.44% | -72.41% | -90.67% |
| Alphatec Holdings ATEC | 1.64B Small-cap | 1.30% | -1.98% | -2.94% | -9.78% | 20.09% | 72.70% | 33.01% | 60.95% |
Ownership & Short Interest
Insider Ownership
3.80%
Institutional Ownership
96.48%
Shares Short
2M
Short Ratio
3.31
Short % of Shares Outstanding
4.63%
Average 10-Day Volume
505K
Average 90-Day Volume
460K
Avanos Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Avanos Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AVNS's 52-week high and low?
- In the last 52 weeks, Avanos Medical reached a high of $25.36 (on September 20, 2024) and a low of $11.21 (on July 16, 2025).
- What is the market cap and P/E ratio for AVNS?
- Curious about Avanos Medical's size and valuation? Its market capitalization stands at 555.39M. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.37, and the forward P/E (looking ahead) is 7.19.
- Does AVNS pay dividends? If so, what's the yield?
- As for dividends, Avanos Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Avanos Medical's main competitors or similar companies to consider before investing?
When looking at Avanos Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT219.83B Healthcare Medical Devices 15.00% 17.17% Boston Scientific
BSX157.52B Healthcare Medical Devices 42.91% 160.06% UFP Technologies
UFPT1.86B Healthcare Medical Devices -24.85% 166.60% QuidelOrtho
QDEL1.85B Healthcare Medical Devices -39.44% -72.41% Alphatec Holdings
ATEC1.64B Healthcare Medical Devices 72.70% 33.01% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Avanos Medical Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Avanos Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -36.78%, the Debt to Equity ratio from the most recent quarter is 16.79, and its Gross Profit Margin stands at 53.61%.
- What is the recent revenue and earnings growth for AVNS?
- Looking at Avanos Medical's growth, its revenue over the trailing twelve months (TTM) was $689M. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.80%, and quarterly earnings saw a YoY growth of 0.84%.
- How much of AVNS stock is held by insiders and institutions?
- Wondering who owns Avanos Medical stock? Company insiders (like executives and directors) hold about 3.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.